Recent posts

TypePostAuthorRepliesLast updated
Blog entryAmendment to the Gilead-Ranbaxy License Agreement Judit Rius07 years 22 weeks ago
Blog entryChilean official takes helm of WIPO patent committee thiru07 years 22 weeks ago
Blog entryWIPO patent committee embarks on positive agenda thiru07 years 22 weeks ago
Blog entryDevelopment Agenda discussions focus on costing of consultants and business analysts thiru07 years 22 weeks ago
Blog entryPhRMA comments on ACTA: ISP Liability, Parallel Trade and Generic APIs James Love07 years 22 weeks ago
Blog entryWIPO Development Agenda committee: Interface between competition policy and intellectual property thiru07 years 22 weeks ago
Blog entryWIPO enriched by in-depth discussions of the public domain thiru07 years 22 weeks ago
StoryKEI Comments on the XM/Sirius Merger James Love07 years 22 weeks ago
StoryKEI Statement on breakdown of Broadcast Treaty negotiation James Love07 years 22 weeks ago
StoryKEI Statement on conclusion of WIPO Development Agenda negotiations James Love07 years 22 weeks ago
StoryKnowledge Ecology International (KEI) General Statement at 4th Session of WIPO PCDA James Love07 years 22 weeks ago
PageKEI Statement on Eshoo/Barton amendment on biosimilars James Love07 years 22 weeks ago
Blog entryMore on the White House/PhRMA deal James Love07 years 22 weeks ago
Blog entryWhite House Redacts Contract Details for Recovery.gov James Love07 years 22 weeks ago
Imagemodern James Love07 years 22 weeks ago
Book pageSelected research reports and papers published elsewhere James Love07 years 22 weeks ago
Book pageApril 9, 2009. KEI brownbag with Peter Brantley, Director of the Internet Archives Malini Aisola07 years 22 weeks ago
Book page June 10, 2009. KEI, TACD and HAI briefing on IPR Enforcement Malini Aisola07 years 22 weeks ago
Book pageJune 30, 2009. KEI brownbag on Access to Medicines & IP in Brazil Malini Aisola07 years 22 weeks ago
Book pagePublic Knowledge Goods Manon Ress07 years 22 weeks ago
PageOpen Access Manon Ress07 years 22 weeks ago
ImageJeffrey Kindler, CEO of Pfizer James Love07 years 22 weeks ago
ImageJeff Kindler James Love07 years 22 weeks ago
ImageThe EPO considers radical IPR scenarios James Love07 years 22 weeks ago